Literature DB >> 6220605

Down syndrome--a disruption of homeostasis.

B L Shapiro.   

Abstract

A major question in human genetics concerns the relationship between the extra chromosome material in the Down syndrome (DS) and its effects. It is suggested here that a generalized disruption of evolved genetic balance in cells of affected individuals leads to decreased developmental and physiological buffering against genetic and environmental forces. Examples of consequences in DS of this model of disruption of homeostasis are presented: i) increased variance for metric traits, ii) amplified instability of developmental pathways, iii) reduced precision of physiological homeostatic controls, and iv) generalized increased morbidity. Evolution has selected for interacting systems. When this evolved balance is disrupted, as in autosomal aneuploidy, the organism is generally disrupted. The model emphasizes the role of environment in producing much of the DS phenotype. Traits less buffered than others in the general population are the ones most disturbed in DS and account for much of the DS phenotype.

Entities:  

Keywords:  Biology; Chromosome Abnormalities--indications; Diseases; Genetics; Homeostasis--complications; Incidence; Measurement; Neonatal Diseases And Abnormalities; Physiology; Research Methodology

Mesh:

Substances:

Year:  1983        PMID: 6220605     DOI: 10.1002/ajmg.1320140206

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  42 in total

1.  Malignancies in Down syndrome.

Authors:  P Kusumakumary; T S Vats; R Ankathil; H R Gattamaneni; M K Nair
Journal:  Indian J Pediatr       Date:  1997 Nov-Dec       Impact factor: 1.967

Review 2.  Auto-catalysed progression of aneuploidy explains the Hayflick limit of cultured cells, carcinogen-induced tumours in mice, and the age distribution of human cancer.

Authors:  D Rasnick
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

3.  Overexpression of amyloid-β protein precursor induces mitochondrial oxidative stress and activates the intrinsic apoptotic cascade.

Authors:  Matthew G Bartley; Kristin Marquardt; Danielle Kirchhof; Heather M Wilkins; David Patterson; Daniel A Linseman
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 4.  Prospects for improving brain function in individuals with Down syndrome.

Authors:  Alberto C S Costa; Jonah J Scott-McKean
Journal:  CNS Drugs       Date:  2013-09       Impact factor: 5.749

5.  Analysis of gene-dosage effects on the expression of CD18 by trisomy 21 lymphoblastoid cell-lines using a statistical model to fit flow cytometry profiles.

Authors:  W G Bardsley; B P McMurray; A Robson; S D'Souza; G M Taylor
Journal:  Hum Genet       Date:  1990-12       Impact factor: 4.132

Review 6.  Evolving homeostatic tissue using genetic algorithms.

Authors:  Philip Gerlee; David Basanta; Alexander R A Anderson
Journal:  Prog Biophys Mol Biol       Date:  2011-03-23       Impact factor: 3.667

7.  Collagen and fibronectin synthesis by trisomic and triploid fibroblasts from human spontaneous abortuses.

Authors:  A A Delvig; V I Kukharenko; V M Belkin; V I Mazurov; K N Grinberg; S S Debov
Journal:  Mol Gen Genet       Date:  1987-10

8.  Segmental trisomy of chromosome 17: a mouse model of human aneuploidy syndromes.

Authors:  Tomás Vacík; Michael Ort; Sona Gregorová; Petr Strnad; Radek Blatny; Nathalie Conte; Allan Bradley; Jan Bures; Jirí Forejt
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-08       Impact factor: 11.205

9.  Evolved developmental homeostasis disturbed in LB1 from Flores, Indonesia, denotes Down syndrome and not diagnostic traits of the invalid species Homo floresiensis.

Authors:  Maciej Henneberg; Robert B Eckhardt; Sakdapong Chavanaves; Kenneth J Hsü
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

10.  Transchromosomic cell model of Down syndrome shows aberrant migration, adhesion and proteome response to extracellular matrix.

Authors:  Frédéric Delom; Emma Burt; Alex Hoischen; Joris Veltman; Jürgen Groet; Finbarr E Cotter; Dean Nizetic
Journal:  Proteome Sci       Date:  2009-08-28       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.